Merkel Cell Polyomavirus targets SET/PP2A complex to promote cellular proliferation and migration.

Area of Science:

• Oncology
• Molecular Biology
• Dermatology

Background:

• Merkel Cell Carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer.
• Previous research identified NDRG1 as crucial for inhibiting MCC cell proliferation and migration.
• The role of genes modulated by the Merkel cell polyomavirus (MCPyV) early genes in MCC requires further elucidation.

Purpose of the Study:

• To investigate the upstream regulators of NDRG1 modulated by MCPyV early genes in MCC.
• To explore the therapeutic potential of targeting the SET protein in MCC treatment.

Main Methods:

• Investigated SET protein expression in MCC cell lines (hTERT-HK-MCPyV and MCPyV+) and tumor tissues.
• Utilized the small molecule inhibitor FTY720 to disrupt the SET-PP2A interaction.
• Employed short hairpin RNA (shRNA) for SET inhibition.
• Assessed cell proliferation, migration, cell cycle regulators (cyclinD1, CDK2), and colony formation.

Main Results:

• Identified SET protein (intrinsic inhibitor of PP2A) as being modulated by MCPyV early genes and upstream of NDRG1 in MCC.
• Strong SET expression was observed in MCC dermal tumor tissues.
• Inhibition of SET-PP2A interaction using FTY720 increased NDRG1 expression and suppressed cell cycle regulators (cyclinD1, CDK2) in hTERT-HK-MCPyV cells.
• SET inhibition via shRNA and FTY720 significantly decreased cell proliferation and colony formation in MCPyV+ MCC cells.

Conclusions:

• The SET protein plays a significant role in MCC pathogenesis by modulating NDRG1 and influencing cell proliferation.
• Targeting the SET-PP2A interaction presents a potential therapeutic strategy for Merkel Cell Carcinoma.
• Drugs targeting the SET protein could offer a novel treatment approach for MCC patients.